GL2907
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GL2907, covering 2014-11-13 to 2014-11-13. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers [Phase 1]